PPG (PPG) Form 4: 14.9168 Deferred Phantom Stock Units Reported
Rhea-AI Filing Summary
Amy R. Ericson, Senior Vice President, Performance & Materials Coatings at PPG Industries (PPG), reported an acquisition of 14.9168 phantom stock units in the PPG Deferred Compensation Plan on 09/30/2025. The filing states these phantom units convert to common stock on a one-for-one basis and are valued at $105.11 per share for purposes of the report. After the reported transaction the filing shows 132.6151 shares attributable to Ms. Ericson under the plan. The phantom units represent interests in an unfunded unitized stock fund and may change in number based on the fair market value of PPG common stock and cash in the fund; conversion to actual shares occurs after termination of employment.
Positive
- Transparent disclosure of deferred-compensation units by an officer under Section 16
- Phantom units convert one-for-one to common stock, making future ownership impact clear
- Valuation provided in the filing at $105.11 per share for the reported units
Negative
- None.
Insights
TL;DR: Insider acquired a small number of deferred-share units tied to PPG stock value; transaction is routine and non-dilutive.
The Form 4 documents an award of 14.9168 phantom stock units that convert one-for-one to common shares after employment termination. Valued at $105.11 each in the filing, the units increase Ms. Ericson's plan-linked position to 132.6151 shares equivalent. This is a deferred-compensation mechanism rather than an open-market purchase or sale, so it does not immediately affect outstanding share count. The entry is informational for ownership tracking but is not a material corporate event.
TL;DR: Transaction appears to be standard deferred-compensation reporting by an officer; disclosure aligns with Section 16 requirements.
The filing identifies Ms. Ericson as an officer and reports phantom stock units held in the company Deferred Compensation Plan. The explanatory note clarifies conversion timing and valuation mechanics, which is consistent with typical executive deferred equity arrangements. The use of an attorney-in-fact signature is documented. There are no indications of unusual terms or immediate insider trading activity in this Form 4.